Breakout Activity
Historical Narratives, Industrial Mass Production, and Public Health Evolution of Penicillin
Conceptual Framework: Constructing Historical Narratives
Historical narratives are deliberate constructions designed to fulfill specific social, institutional, and political functions rather than neutral chronological records.
The history of medical discoveries like penicillin is shaped through competing framework narratives that emphasize different aspects of scientific inquiry, industrial capacity, and therapeutic impact.
Analyzing penicillin requires examining how different eras constructed narratives—ranging from individual genius and accidental discovery to state-directed mass production, corporate innovation, and public stewardship.
The "Accidental Discovery" vs. "Wonder Drug" Narratives

The "Accidental Discovery" Narrative:
Centers on Professor Alexander Fleming’s 1928 observation at St. Mary's Hospital in London, where a stray mold spore (Penicillium notatum) contaminated a bacterial culture plate.
Focuses on individual observation, serendipity, laboratory chance, and the visual trope of a clearing halo where mold kills surrounding Staphylococcus bacteria.
Frames scientific progress as a sudden, individual insight arising from fortuitous laboratory accidents.
The "Wonder Drug" Narrative:
Centers on the transformative therapeutic power, clinical efficacy, and miracle-like curative properties of processed antibiotic capsules and injectables.
Focuses on standardized dosages, dramatic patient recoveries, and the total eradication of previously fatal bacterial infections.
Visualized through mass-marketed pharmaceutical pills, hypodermic vials, and broad population-level health improvements.
Synthesis and Missing Dimensions:
Both standard narratives obscure the vast collective effort required to transform raw laboratory mold into a purified, mass-produced pharmaceutical product.
Comprehensive historical framing requires combining individual discovery with chemical extraction, clinical trials, government-funded war efforts, scale-up engineering, and corporate distribution.
WWII Mass Production, Industrial Scaling, and Corporate Advertising
Wartime Acquisition and Industrial Expansion:
In 1943, Bristol-Myers acquired Cheplin Laboratories in Syracuse, NY, providing the industrial facilities required to mass-produce penicillin for World War II military forces.
Production scaled dramatically from across the entirety of 1943 to over in the single month of May 1944.
A total of American pharmaceutical plants reached capacity, achieving a collective output rate of , sufficient to treat .
United States manufacturing plants generated of the world's total penicillin supply during World War II.
Corporate Positioning and Commercial Advertisements:
Chas. Pfizer & Co., Inc. (established 1849; 81 Maiden Lane, NY and 444 West Grand Ave, Chicago) advertised itself as the world's largest producer of penicillin, characterizing its manufacturing capacity as an outstanding public service.
E. R. Squibb & Sons emphasized rigorous scientific standards across its household chemical lines (Dental Cream, Cold Cream, Nursery Powder, Boric Acid, Epsom Salt, Castor Oil, Milk of Magnesia, Sodium Bicarbonate), operating under the corporate motto: "The 'Priceless Ingredient' of Every Product is the Honor and Integrity of Its Maker."
Schenley Laboratories, Inc. (Lawrenceburg, Indiana) published wartime advertisements ("Thanks to PENICILLIN… He Will Come Home!") highlighting its industrial transition from fermentation research to mass-producing Penicillium notatum alongside other government-designated firms. Schenley also sponsored the C.B.S. radio broadcast "THE DOCTOR FIGHTS" starring Raymond Massey.
Bristol Laboratories Inc. (Syracuse, NY) marketed Flo-Cillin "96" (Procaine Penicillin G in Oil, with Aluminum Monostearate), which maintained therapeutic blood levels for in of patients from a single injection, eliminating the need for daily injections.
Parke, Davis & Company (Detroit 32, Mich.) showcased global soil sampling (screening samples from Borneo, Brazil, New Zealand, and US backyards), evaluating up to micro-organism cultures annually to discover new antibiotic compounds against long odds ().
The New York Quinine & Chemical Works Inc. (NYQ; Brooklyn, NY and St. Louis Depot) advertised chemical purity controls in manufacturing raw fine chemicals (potassium iodide, codeine salts, morphine salts, brucine, strychnine, cinchona alkaloids, opium gum, and thymol iodide) in 1937.
Biological Laboratories / Cheplin's Penicillin promoted penicillin as an international cooperative triumph involving British and American scientists, the Rockefeller Foundation, the National Research Council, the US Department of Agriculture, the War Production Board, and private industry.
Media Reception, Nobel Laureates, and Early Clinical Triumphs

Nobel Prize in Physiology or Medicine (1945):
On Friday, October 26, 1945, The New York Times announced that the Nobel Prize in Physiology or Medicine was awarded jointly to Sir Alexander Fleming, Dr. Ernst B. Chain (a German refugee biochemist), and Sir Howard W. Florey.
Dr. Chain emphasized how his biochemical work at Oxford expanded upon Fleming's original 1928/1929 papers to extract, purify, and stabilize the compound.
Early Publicized Clinical Successes:
The New York Times (August 26, 1943) reported on a survey of clinical cases evaluated by the Committee on Chemotherapeutic and Other Agents (Division of Medical Sciences, National Research Council), confirming penicillin as a potent antibacterial agent effective via intravenous, intramuscular, or topical administration, while explicitly warning that it was ineffective when taken orally.
Newspaper dispatches celebrated miraculous clinical recoveries, including saving a soldier suffering from an otherwise fatal bacterial brain disorder and healing a severe war wound old in just .
Public health reporting emphasized penicillin's superior efficacy in severe infections where sulfa drugs had completely failed.
Commercialization, Consumer Germicides, and Early OTC Antibiotics
Pre-Antibiotic Antiseptic Marketing:
Lambert Pharmacal Company (St. Louis, Mo.) marketed Listerine Antiseptic, claiming it killed (specifically Staphylococcus aureus and Bacillus typhosus) in .
Advertisements urged dousing open cuts, wounds, bruises, and stings, as well as daily mouth gargling for colds and sore throats.
Listerine published 12-year study statistics involving over people, asserting that non-garglers suffered more severe colds, longer cold duration in days, more sore throats, and more ordinary colds.
The Bauer Chemical Company marketed Formamint throat tablets (1923), recommending daily mouth dissolution to release germicides into saliva to destroy throat pathogens.
Post-WWII Commercial Antibiotic Products:
Pfizer commercialized over-the-counter antibiotic preparations under the Candettes brand name.
Candettes Antibiotic Troches featured a dual mechanism: double antibiotic action (combining Bacitracin and Polymyxin B) to kill bacteria on contact, paired with a local anesthetic (Benzocaine) to numb inflamed throat tissues.
Product line expansions included Candettes Cough-Jel (a raspberry-flavored squeeze-tube gel launched in 1958), Candettes Cold Tablets, Candettes Cough Lozenges, and Candettes Cough Syrup.
Historical Shift in Public Health Messaging: Wartime Urgency vs. Modern Stewardship

US War Department Propaganda (1942–1945):
Aimed at factory workers constructing production facilities to accelerate penicillin output.
Employed urgent, high-stakes slogans: "A RACE AGAINST DEATH!", "Every minute Lost on this job may mean… [grave of P.F.C. John Doe]", and "Penicillin Saves Soldiers' Lives! Give this job Everything You've got!".
Framed antibiotic access as an unlimited, lifesaving military imperative.
UK Department of Health / NHS Public Stewardship (21st Century):
Shifted focus entirely from production expansion to restrictive usage control to prevent antimicrobial resistance.
Implemented educational campaign posters asserting: "Antibiotics DON'T WORK ON COLDS… OR MOST COUGHS AND SORE THROATS."
Public Health England issued clear diagnostic guidance lists:
Antibiotics DON'T work for: Colds, flu, vomiting, most coughs, most ear infections, most sore throats, most diarrhoea, and most cystitis.
Antibiotics ARE NEEDED for: Serious bacterial infections including sepsis, pneumonia, urinary tract infections, sexually transmitted infections (such as gonorrhoea), and meningococcal meningitis.
Industrial Microbiology and Technical Processing of Penicillin


Scale Transition in Manufacturing (Life Magazine, July 17, 1944):
Replaced slow laboratory surface culture (brewing small batches in half-gallon glass bottles) with deep-culture submerged fermentation in giant industrial steel tanks at plants like Commercial Solvents Corporation in Terre Haute, Indiana.
Continuous growth and fermentation were achieved throughout the liquid medium by pumping sterile air directly into the bottom of the deep tanks.
Maintained strict sterile operating environments: a single invading bacterium would ruin an entire batch of mold solution.
Multi-Step Chemical Processing and Purification:
Seed mold (Penicillium notatum) inoculated into a primary fermentation flask containing sugar/starch nutrient liquid.
Fermented mash filtered to separate fungal mass from the excreted amber penicillin liquid.
Activated charcoal added to absorb raw penicillin solution from the liquid.
Chemical extraction and solvent purification yields pure penicillin solution.
Plastic-masked technicians measure liquid penicillin into sterile vials under surgical operating-room conditions.
High-vacuum low-temperature freeze-drying (lyophilization) removes moisture, transforming unstable liquid penicillin into stable dry powder.
Biological Assays and Mold Strain Research:
Potency testing utilized the cylinder plate assay method: drops of penicillin solution were added to small glass cylinders placed on flat petri dishes seeded with Staphylococcus bacteria. The diameter of the resulting clear, bacteria-free halo measured active potency.
Strain isolation led by Dr. Coghill and Dr. Raper at the US Department of Agriculture Northern Regional Research Laboratory (Peoria, Illinois) screened mold samples from moldy produce (cantaloupes, cheese, bread, cherries) to identify high-yield strains suitable for deep-tank aeration.
Comparative Mycological Organisms:
Penicillium notatum: Greenish mold whose secretion yields therapeutic penicillin.
Penicillium claviforme: Produces patulin, tested historically against the common cold.
Aspergillus clavatus: Produces distinct antibacterial agents.
Penicillium italicum: Causes soft citrus rot on lemons; lacks the medicinal activity of P. notatum.
Neurospora sitophila: Common cottony bread mold; unsuitable for medical antibiotic extraction.